China Pharma Holdings Inc.
CPHI
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.52M
Close$
$-0.33
137.6% downside
Current Fair Value
137.6% downsideOvervalued by 137.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.52 Million |
|---|---|
| Enterprise Value | $-4,791,477,743.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.74 |
| Beta | 1 |
| Outstanding Shares | 4,291,000 |
Return
| Return on Equity | -13.46% |
|---|---|
| Return on Assets | -11.04% |
| Return on Invested Capital | -15.82% |
Valuation & Multiples
| P/E Ratio | -0.96 |
|---|---|
| PEG | -2.11 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -34.16 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 15, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.60%▼ 0.08% |
|---|---|
| Total Invested | $15,719▼ 55.65% |
| Investors Holding | 6▲ 1.00% |
ESG Score
No data
About China Pharma Holdings Inc.
CEO: Zhilin Li